Low-Dose Low-Molecular Weight Heparin (Enoxaparin) Is Effective as Adjuvant Treatment in Active Ulcerative Colitis: An Open Trial
Authors:
- 1 October 2001
- journal article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 46 (10) , 2239-2244
Abstract
Ulcerative colitis is a chronic inflammatory bowel disorder of unknown etiology. Treatment of flare-ups is based on mesalamine and steroids. Treatment of moderate to severe ulcerative colitis with...Keywords
This publication has 36 references indexed in Scilit:
- Low-dose low-molecular-weight heparin (enoxaparin) is beneficial in lichen planus: a preliminary reportJournal of the American Academy of Dermatology, 1998
- Heparin disaccharides inhibit tumor necrosis factor-alpha production by macrophages and arrest immune inflammation in rodentsInternational Immunology, 1997
- Serum Basic Fibroblast Growth Factor in Pediatric Crohn's Disease (Implications for Wound Healing)Digestive Diseases and Sciences, 1997
- Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at HomeNew England Journal of Medicine, 1996
- A disaccharide that inhibits tumor necrosis factor alpha is formed from the extracellular matrix by the enzyme heparanase.Proceedings of the National Academy of Sciences, 1995
- Paradoxical response to heparin in 10 patients with ulcerative colitis.1995
- Effect of heparin, dermatan sulfate, and related oligo-derivatives on human polymorphonuclear leukocyte functions.1993
- Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptorCell, 1991
- Pharmacology and special clinical applications of low‐molecular‐weight heparinsAmerican Journal of Hematology, 1988
- INHIBITION OF HEPARANASE-MEDIATED DEGRADATION OF EXTRACELLULAR-MATRIX HEPARAN-SULFATE BY NON-ANTICOAGULANT HEPARIN SPECIES1987